SGC-CAMKK2-1: A Chemical Probe for CAMKK2

Author:

Wells CarrowORCID,Liang Yi,Pulliam Thomas L.,Lin Chenchu,Awad Dominik,Eduful BenjaminORCID,O’Byrne SeanORCID,Hossain Mohammad AnwarORCID,Catta-Preta Carolina Moura CostaORCID,Ramos Priscila ZonziniORCID,Gileadi OpherORCID,Gileadi Carina,Couñago Rafael M.ORCID,Stork Brittany,Langendorf Christopher G.,Nay Kevin,Oakhill Jonathan S.ORCID,Mukherjee Debarati,Racioppi Luigi,Means Anthony R.,York Brian,McDonnell Donald P.ORCID,Scott John W.,Frigo Daniel E.ORCID,Drewry David H.ORCID

Abstract

The serine/threonine protein kinase calcium/calmodulin-dependent protein kinase kinase 2 (CAMKK2) plays critical roles in a range of biological processes. Despite its importance, only a handful of inhibitors of CAMKK2 have been disclosed. Having a selective small molecule tool to interrogate this kinase will help demonstrate that CAMKK2 inhibition can be therapeutically beneficial. Herein, we disclose SGC-CAMKK2-1, a selective chemical probe that targets CAMKK2.

Funder

National Institutes of Health

NIH Illuminating the Druggable Genome program

Mike Slive Foundation for Prostate Cancer Research

FAPESP

CNPq

AbbVie

Bayer Pharma AG

Boehringer Ingelheim

Canada Foundation for Innovation

Eshelman Institute for Innovation

Genome Canada

Innovative Medicines Initiative

Janssen

Merck KGaA Darmstadt Germany

MSD

Novartis Pharma AG

Ontario Ministry of Economic Development and Innovation

Pfizer

Takeda

Wellcome Trust

Publisher

MDPI AG

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3